A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Conditions
Chronic Myeloid Leukemia, Chronic Phase · Chronic Myeloid Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama Medicine (UAB Medicine), Birmingham, Alabama, United States
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
UC Irvine Health, Orange, California, United States
Rocky Mountain Cancer Centers, LLP, Lone Tree, Colorado, United States
Florida Cancer Specialists - South Region Research Office, Fort Myers, Florida, United States
Florida Cancer Affiliates - Ocala, Ocala, Florida, United States
Florida Cancer Specialists - North Region Research Office, St. Petersburg, Florida, United States
Florida Cancer Specialists - East Region Research Office, West Palm Beach, Florida, United States
Georgia Cancer Center at Augusta University, Augusta, Georgia, United States
Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United States
Atrium Health Levine Cancer Institute, Winston-Salem, North Carolina, United States
Willamette Valley Cancer Institute and Research Center, Eugene, Oregon, United States
Oregon Health & Science University, Portland, Oregon, United States
Thomas Jefferson University - Center City (Philadelphia), Philadelphia, Pennsylvania, United States
Tristar BMT, Nashville, Tennessee, United States
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Monash Medical Centre, Clayton, Victoria, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Royal Perth Hospital, Perth, Western Australia, Australia
Centre Léon Bérard, Lyon, Auvergne-Rhône-Alpes, France
Institut Bergonié, Bordeaux, France
Institut Paoli Calmettes, Marseille, France
CHU de Nantes (University Hospital of Nantes) - Hôtel Dieu, Nantes, France
Hôpital Saint Louis, Paris, France
Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
Universitätsklinikum Aachen, Aachen, Germany
Charité Campus Virchow-Klinikum - Universitätsmedizin Berlin, Berlin, Germany
Universitätsklinikum Frankfurt, Frankfurt am Main, Germany
Medizinische Hochschule Hannover, Hanover, Germany
Universitätsklinikum Jena, Jena, Germany
Universitätsklinikum Mannheim, Mannheim, Germany
Klinikum rechts der lsar der Technischen Universität München, München, Germany
Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Fondazione IRCCS San Gerardo dei Tintori - SC Centro di Ricerca Fase I, Monza, Italy
Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
Auckland City Hospital, Auckland, New Zealand
Christchurch Hospital, Christchurch, New Zealand
Uijeorigbu Eulji Medical Center, Eulji University, Uijeongbu-si, Gyeonggi-do, South Korea
Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggido, South Korea
Dong-A University hospital, Busan, South Korea
Keimyung University Dongsan Hospital, Daegu, South Korea
Hospital Universitari Vall d'Hebrón, Barcelona, Spain
Hospital Clínic de Barcelona, Barcelona, Spain
Hospital Universitari Germans Trias i Pujol (ICO Badalona), Barcelona, Spain
Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, Spain
Hospital Universitario de La Princesa, Madrid, Spain
Hospital Universitario Ramón y Cajal, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital de Día Quirónsalud Zaragoza, Zaragoza, Spain
Imperial College Healthcare NHS Trust, London, England, United Kingdom